Takeda warns of loss after $2.4 bn diabetes drug settlements
Top Japanese drugmaker Takeda Pharmaceutical on Wednesday warned of its first annual loss in more than six decades after agreeing to pay around $2.4 billion to settle lawsuits over its Actos diabetes drug, amid cancer claims.
Apr 29, 2015
0
4